Factors affecting prolonged acute bronchiolitis were premature birth history (p=0.005), infant age group (p=0.03), breastfeeding < 2 months (p=0.02), tachypnea in admission (p
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Aim: The aim of this study is to find out the independent risk factors that affect the period of hospitalization in acute bronchiolitis.Material and Methods: The patients who were hospitalized with the diagnosis of bronchiolitis at the Pediatric Emergency and Intensive Care Unit were included.Results: 61 (64 %) of the patients were males and 34 (36%) were females.
📊
Key Findings & Data:The median age of the patients was 7 (1.5-23) months.
💡
Conclusion & Impact:Factors affecting prolonged acute bronchiolitis were premature birth history (p=0.005), infant age group (p=0.03), breastfeeding < 2 months (p=0.02), tachypnea in admission (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Aim: The aim of this study is to find out the independent risk factors that affect the period of hospitalization in acute bronchiolitis.Material and Methods: The patients who were hospitalized with the diagnosis of bronchiolitis at the Pediatric Emergency and Intensive Care Unit were included.Results: 61 (64 %) of the patients were males and 34 (36%) were females. The median age of the patients was 7 (1.5-23) months. The median hospitalization period was 6 (3-18) days. Factors affecting prolonged acute bronchiolitis were premature birth history (p=0.005), infant age group (p=0.03), breastfeeding < 2 months (p=0.02), tachypnea in admission (p
🔖
Cite This Article
ASLAN, M., SELEN, R., TOPAL, E. (2022). The independent risk factors that affect the hospitalization of acute bronchiolitis. Annals of Medical Research, Cilt: 26 - Sayı: 3, 318–321. https://ajindex.com/articles/446766
Güler N, Kılıç G, Bronşiyolit.Neyzi O, ve ark. Pediatri 4. Baskı, İstanbul. Nobel Tıp Kitapevleri Ltd Şti 2010;1086-7
Goodman D. Bronchiolitis. Ed: Behrman RE, Kliegman RM, Jenson HB. Nelson textbook of pediatrics 19th edition. Philadelphia: WB Saunders Co 2011:1456-9
Yalçın E, Karadağ B, Uzuner N, ve ark. Türk Toraks Derneği Akut Bronşiyolit Tanı ve Tedavi Uzlaşı Raporu. Türk Toraks Dergisi 2009;10:3-7
Jartti T, Aakula M, Mansbach JM, et al. Hospital length-of-stay is associated with rhinovirus etiology of bronchiolitis. Pediatr Infect Dis J 2014;33:829-34
Thorburn K. Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection. Arch Dis Child 2009;94:99-103
Mull CC, Scarfone RJ, Ferri LR, et al. A randomize trial of nebulized epinephrine vs. albuterol in the ED treatment of bronchiolitis. Arch PediatrAdolesc Med 2004;158:113-8
Fitzgerald AD, Kilham HA. Bronchiolitis: assessment and evidence based management. Med J Aust 2004;180:399-404
Lanari M, Prinelli F, Adorni F, et al. Risk factors for bronchiolitis hospitalization during the first year of life in a multicenter Italian birth cohort. Ital J Pediatr 2015;41:40
Di Franza JR, Masaquel A, Barrett AM, et al. Systematic literature review ssessing tobacco smoke exposure as a risk factor for serious respiratory syncytial virus disease among infants and young children. BMC Pediatr 2012;12:81
Da Dalt L, Bressan S, Martinolli F, et al. Treatment of bronchiolitis: state of art. Early Hum Dev 2013;89:31-6
Dixon DL. The role of human milk immunomodulators in protecting against viral bronchiolitis and development of chronic wheezing illness. Children (Basel) 2015;2:289-304
Sala KA, Moore A, Desai S, et al. Factors associated with disease severity in children with bronchiolitis. J Asthma 2015;52:268-72.